UMR CNRS 5558 Laboratoire de Biométrie et Biologie Évolutive

article :
Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delphine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Gollier G, Gommeaux A, Claudel J-P, Bourlon F, Bertrand B, Van Belle E, Laskar M, Investigators the FRANCE 2 (2012)
Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients, The New England Journal of Medicine, vol. 366 pp.1-11

Lièvre M, Moulin P, Thivolet C, Rodier M, Rigalleau V, Penfornis A, Pradignac A, Ovize M (2011)
Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening, Trials, vol. 12(23) pp.1-7

Villar E, Lièvre M, Kessler M, Lemaitre V, Alamartine E, Rodier M, François M, Zaoui P, Moranne O, Choukroun G, Guerraoui A, Jolivot A, Janin G, Branger B, Heng AE, Boudray C, Bissery A, Rabilloud M, Pouteil-Noble C (2011)
Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial, Journal of Diabetes and Its complications, vol. pp.1-7

Boissel J-P, Cucherat M, Nonyc P, Chabaud S, Gueyffier F, Wright JM, Lièvre M, Leizorovicz A (2008)
New insights on the relation between untreated and treated outcomes for a given therapy effect model is not necessarily linear, Journal of Clinical Epidemiology, vol. 61(3) pp.301-307

Roussel R, Mentre F, Bouchemal N, Hadjadj S, Lièvre M, Chatellier G, Menard J, Panhard X, Le Henanff A, Marre M, Le Moyec L (2007)
NMR-based prediction of cardiovascular risk in diabetes, Nature Medicine, vol. 13 pp.399-400

Azizi M, Menard J, Peyrard S, Lièvre M, Marre M, Chatellier G (2006)
Assessment of Patients` and Physicians` Compliance to an ACE Inhibitor Treatment Based on Urinary N-Acetyl Ser-Asp-Lys-Pro Determination in the Noninsulin-Dependent Diabetes Hypertension Microalbuminuria Proteinuria Cardiovascular Events and Ramipril (DIABHYCAR) Study, Diabetes Care, vol. 29 pp.1331-1336

Liard F, Le Heuzey JY, Jaillon P, Lièvre M, Danchin N (2006)
Flecainide acetate utilisation review among general practitioners and hospital or office-based cardiologists in France. Obepine: observational study of flecainide, Annales de cardiologie et d`angéiologie, vol. 55 pp.113-122

Lièvre M (2006)
Evaluation of adverse treatment effects in controlled trials, Joint Bone Spine, vol. 73 pp.624-626

Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, Larrue V, Lièvre M, Leys D, Bonneville JF, Watelet J, Pruvo JP, Albucher JF, Viguier A, Piquet P, Garnier P, Viader F, Touze E, Giroud M, Hosseini H, Pillet JC, Favrole P, Neau JP, Ducrocq X (2006)
Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis, New England Journal of Medicine, vol. 355 pp.1660-1671

Barna A, Baudet M, Cambou J-P, Chatellier G, Cucherat M, Dallongeville J, Durlach V, Giral P, Gueyffier F, Kownator S, Lang T, Léonard D, Pace E, Paillard F, Vallée J-P, Vergès B, Aquino J-P , Aulanier S, Balarac N, Beucler I, Bobrie G, Caporossi L, Dénolle T, D`Ivernois C, Dumarcet N, Erpeldinger S, Farnier M, Ferrières J, Fischer C, Friocourt P, Girerd X, Godin M, Halimi S, Jean T, Lièvre M, Loirat P, Lucas C, Marechaud R, Marre M, Ménard J, Mimran A, Moulin P, Picard S, Poncelet P, Pouchain D, Scarabin P-Y, Seux M-L, Senechal M, Sicard D, Turpin G, Vaisse B, Vallée J (2005)
Methods for evaluation of total cardiovascular risk, Médecine thérapeutique, vol. 11 pp.233-236

Lièvre M, Abadie E (2005)
Discontinuation of Vioxx, Lancet, vol. 365 pp.23-24

Lièvre M, Marre M, Robert JJ, Charpentier G, Iannascoli F, Passa P (2005)
Cross-sectional study of care socio-economic status and complications in young French patients with type 1 diabetes mellitus, Diabetes and Metabolism, vol. 31 pp.41-46

Argaud L, Rioufol G, Lièvre M, Bontemps L, Legalery P, Stumpf M, Finet G, Itti R, Andre-Fouet X, Ovize M (2004)
Preconditioning during coronary angioplasty: no influence of collateral perfusion or the size of the area at risk, European Heart Journal, vol. 25 pp.2019-2025

Lievre M (2004)
Type 2 diabetes and cardiovascular risk: Lessons from therapeutic trials, Médecine thérapeutique, vol. 10 pp.304-315

Marre M, Lièvre M, Chatellier G (2004)
Trial finds low dose ramipril does not reduce cardiovascular or renal events in people with type 2 diabetes and albuminuria, Evidence-based cardiovascular medicine, vol. 8 pp.273-274

Marre M, Lièvre M, Chatellier G, Mann JFE, Passa P, Menard J (2004)
Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised double blind placebo controlled trial (the DIABHYCAR study), British Medical Journal, vol. 328 pp.495-499

Mas JL, Chatellier G, Beyssen B, Branchereau A, Becquemin JP, Bonneville JF, Crochet D, Gauz JC, Larrue V, Leys D, Watelet J, Hommel M, Magne JL, Mounier-Vehier F, Boyer L, Favre JP, Giroud M, Hassen-Kodja K, Ricco JB, Pruvo JP, Meder JF, Arquizan C, Becker F, Cattin F, Debray JM, Jausseran JM, Long A, Touboul PJ, Lièvre M, Beregi JP, Bogousslavsky J, Testart M (2004)
Carotid angioplasty and stenting with and without cerebral protection - Clinical alert from the Endarterectomy versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial, Stroke, vol. 35 pp.E18-E20

Robert R, Rioufol G, Finet G, Cottin Y, Tabib A, Zeller M, Wolf JE, Lièvre M, Bricca G (2004)
Experimental assessment of new stent technologies: validation of a comparative paired rabbit iliac artery study model, Journal of Biomedical Materials Research, vol. 70B pp.303-310

Yzèbe D, Lièvre M (2004)
Fish oils in the care of coronary heart disease patients: a meta-analysis of randomized controlled trials, Fundamental & Clinical Pharmacology, vol. 18(5) pp.581-592

Bruckert E, Lièvre M, Giral P, Crepaldi G, Masana L, Vrolix M, Leitersdorf E, Dejager S (2003)
Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients, The American Journal of Geriatric Cardiology, vol. 12 pp.225-233

Hadjadj S, Gallois Y, Alhenc-Gelas F, Chatellier G, Marre M, Genes N, Lièvre M, Mann J, Menard J, Vasmant D (2003)
Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients, Diabetic Medicine, vol. 20 pp.677-682

Lièvre M (2003)
Les biais en recherche clinique, Revue du Praticien, vol. 53 pp.2096-2098

Vaur L, Gueret P, Lièvre M, Passa P (2003)
Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: lessons from the Diabhycar study, Diabetes Care, vol. 26 pp.855-860

Villar E, Lièvre M, Labeeuw M, Pouteil-Noble C (2003)
Protocole de l’étude NEPHRODIAB2, Néphrologie, vol. 24(6) pp.317-319